In addition, the fact that insomnia significantly influences BDNF levels more than cognitive decline suggests that insomnia may be in part responsible for cognitive decline in the early stages; thus, insomnia may be considered as a potential therapeutic target for the prevention of cognitive decline in older adults. The gene discussed is BDNF; the disease is insomnia measurement.